Mitral Valve Prolapse

Mitral Valve Prolapse is a topic covered in the 5-Minute Emergency Consult.

To view the entire topic, please log in or purchase a subscription.

Emergency Central is a collection of disease, drug, and test information including 5-Minute Emergency Medicine Consult, Davis’s Drug, McGraw-Hill Medical’s Diagnosaurus®, Pocket Guide to Diagnostic Tests, and MEDLINE Journals created for emergency medicine professionals. Explore these free sample topics:

Emergency Central

Peripheral Vascular DiseasePeripheral Vascular Disease

Abdominal pain, right lower quadrantAbdominal pain, right lower quadrant

dilTIAZemdilTIAZem

Arterial blood gasesArterial blood gases

-- The first section of this topic is shown below --

Basics

Description

  • Bulging of 1 or both of the mitral valve leaflets into the left atrium during systole
  • Occurs when the leaflet edges of the mitral valve do not coapt
  • Commonly due to abnormal stretching of 1 of the mitral valve leaflets during systole:
    • Myxomatous proliferation of the spongiosa layer within the valve causing focal interruption of the fibrosa layer
    • Excessive stretching of the chordae tendineae, leading to traction on papillary muscles
  • Theoretical explanations for associated chest pain:
    • Focal ischemia from coronary microembolism due to platelet aggregates and fibrin deposits in the angles between the leaflets
    • Coronary artery spasm
  • Mitral regurgitation (MR) may occur in some patients
  • Age of onset is 10–16 yr
  • Female > male (3:1)
  • Typically benign in young women, whereas men >50 yr tend to have serious sequelae and more often develop severe regurgitation requiring surgical intervention
  • Can be identified by ECG in 2–4% of the general population and in 7% of autopsies
  • A variety of neuroendocrine and autonomic disturbances occur in some patients
  • Genetics:
    • Strong hereditary component
    • Sometimes transmitted as an autosomal dominant trait with varying penetrance

Etiology

  • Marfan syndrome
  • Relapsing polychondritis
  • Ehlers–Danlos syndrome (i.e., types I, II, IV)
  • Osteogenesis imperfecta
  • Pseudoxanthoma elasticum
  • Stickler syndrome
  • Systemic lupus erythematosus
  • Polyarteritis nodosa
  • Polycystic kidney disease
  • von Willebrand syndrome
  • Duchenne muscular dystrophy

-- To view the remaining sections of this topic, please log in or purchase a subscription --

Basics

Description

  • Bulging of 1 or both of the mitral valve leaflets into the left atrium during systole
  • Occurs when the leaflet edges of the mitral valve do not coapt
  • Commonly due to abnormal stretching of 1 of the mitral valve leaflets during systole:
    • Myxomatous proliferation of the spongiosa layer within the valve causing focal interruption of the fibrosa layer
    • Excessive stretching of the chordae tendineae, leading to traction on papillary muscles
  • Theoretical explanations for associated chest pain:
    • Focal ischemia from coronary microembolism due to platelet aggregates and fibrin deposits in the angles between the leaflets
    • Coronary artery spasm
  • Mitral regurgitation (MR) may occur in some patients
  • Age of onset is 10–16 yr
  • Female > male (3:1)
  • Typically benign in young women, whereas men >50 yr tend to have serious sequelae and more often develop severe regurgitation requiring surgical intervention
  • Can be identified by ECG in 2–4% of the general population and in 7% of autopsies
  • A variety of neuroendocrine and autonomic disturbances occur in some patients
  • Genetics:
    • Strong hereditary component
    • Sometimes transmitted as an autosomal dominant trait with varying penetrance

Etiology

  • Marfan syndrome
  • Relapsing polychondritis
  • Ehlers–Danlos syndrome (i.e., types I, II, IV)
  • Osteogenesis imperfecta
  • Pseudoxanthoma elasticum
  • Stickler syndrome
  • Systemic lupus erythematosus
  • Polyarteritis nodosa
  • Polycystic kidney disease
  • von Willebrand syndrome
  • Duchenne muscular dystrophy

There's more to see -- the rest of this topic is available only to subscribers.

© 2000–2023 Unbound Medicine, Inc. All rights reserved